@GabrielSilMetis Nao acho que os EUA sao mais referências em inovação belicas, olha pelo fracasso da marinha deles de nao conseguirem contruir nova classe de flagatas ou substituir seus destroyes, problemas com kc-46 pegasus e entre outros..
@beto_caiafa Caiafa, me tira uma duvida, os centauros 2 do EB escolheram , sao da hitfact com carregador manual ou automático? pois em um video do EB, mostra uma apresentação com tres tripulantes.
@meodeia21 O sub nuclear vale o equivalente a uns 4 sub diesel elétricos por causa da sua velocidade e autonomia, o idel era ter uns 6 diesel elétricos para defender bases e portos e uns 3 nuclear para defender comboios ou vias marítimas longe da costa
🚨 PLEASE HELP: EVERY SHARE COULD MAKE A DIFFERENCE.
Lito is battling a rapidly progressing and devastating disease. Time is critical, and we are trying to get his case in front of the researchers and institutions who may be able to help.
Please help us reach:
@ionispharma@broadinstitute@HarvardMed@MayoClinic
If you know anyone connected to these institutions or clinical trials, please tag them, share this post, and help us get Lito’s story to the right people.
Sometimes one share can reach the person who can open the right door. 🙏
Please help Lito.
Urgent appeal for Lito Sousa, fighting Creutzfeldt-Jakob disease. Please share this reel far and wide. Make sure to tag these institutions who could include him in life-saving trials:
Quer ajudar o Lito? Compartilhe este reel na sua rede e marque as instituições abaixo.
Cada segundo conta: 📌 @ionis_pharma — Ionis Pharmaceuticals — ION717 trial @broadinstitute
— PRiSM trial (NCT07444580) @harvard@mayoclinic
Every share and tag can make a difference. Time is critical.” #lito #SaveLito #CreutzfeldtJakob
🚨Urgent appeal for Lito Sousa @avioesemusicas, fighting Creutzfeldt-Jakob disease.
Please share this reel far and wide. https://t.co/9otgGSQRhQ
Make sure to tag these institutions who could include him in life-saving trials:
📌@ionis_pharma — Ionis Pharmaceuticals — ION717 trial
📌@broadinstitute — PRiSM trial (NCT07444580)
📌@harvard
📌@mayoclinic